Category: GLOBE-NEWSWIRE

Posted on

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation

PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory mycosis fungoides and Sézary syndrome, two subtypes of cutaneous T-cell lymphoma, will be featured at the World Congress of Cutaneous Lymphomas (WCCL) in Montréal, Canada.

Drawing on complementary evidence streams, including patient-reported outcomes, comparative-effectiveness estimates, molecular biomarker signals, and real-world utilization, these analyses collectively provide a more complete understanding of the therapeutic profile and potential of mogamulizumab.

“The research being presented at WCCL reflects our continued commitment to generating evidence beyond initial clinical trials for mogamulizumab in patients with relapsed or refractory mycosis fungoides and Sézary syndrome,” said Daniela van Eickels, MD, PhD, MPH, Chief Medical Officer, Kyowa Kirin North America. “In these difficult-to-treat blood cancers, innovative clinical research and real-world data generation is essential to advancing and informing treatment strategies. We look forward to sharing our findings and exchanging ideas with the expert community.”

WCCL Presentations:

Improved symptoms and health-related quality of life in patients with mycosis fungoides and Sézary syndrome treated with mogamulizumab in the PROSPER study
Oral Presentation; Scientific Session 8A
Friday, June 26, 3:30-4:30 PM ET

Outcomes in relapsed/refractory mycosis fungoides or Sézary syndrome from the MAVORIC trial mogamulizumab arm versus a real-world Australian cohort receiving vorinostat
(Collaborative Study)
Oral Presentation; Scientific Session 3B
Thursday, June 25, 2:30-3:30 PM ET

Overall survival in patients with mycosis fungoides or Sézary syndrome in Denmark: comparative effectiveness of mogamulizumab versus standard of care
Oral Presentation; Scientific Session 3B
Thursday, June 25, 2:30-3:30 PM ET

Targeted sequencing in patients with relapsed/refractory mycosis fungoides mogamulizumab or Sézary syndrome treated with mogamulizumab in the MOGA-2MG-Q4W clinical trial 
Oral Presentation; Scientific Session 4B
Thursday, June 25, 3:40-5:20 PM ET

Mogamulizumab treatment for mycosis fungoides in clinical practice in France: data from the ongoing multicentric prospective observational PROMED study
Exhibit Hall Poster Session
Thursday-Saturday, June 25-27

U.S. POTELIGEO (mogamulizumab-kpkc) Indication
POTELIGEO injection for intravenous infusion is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.

Important Safety Information

WARNINGS AND PRECAUTIONS

Dermatologic toxicity: Monitor patients for rash throughout the course of treatment. For patients who experienced dermatologic toxicity in Trial 1, the median time to onset was 15 weeks, with 25% of cases occurring after 31 weeks. Interrupt POTELIGEO for moderate or severe rash (Grades 2 or 3). Permanently discontinue POTELIGEO for life-threatening (Grade 4) rash or for any Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).

Infusion reactions: Most infusion reactions occur during or shortly after the first infusion. Infusion reactions can also occur with subsequent infusions. Monitor patients closely for signs and symptoms of infusion reactions and interrupt the infusion for any grade reaction and treat promptly. Permanently discontinue POTELIGEO for any life-threatening (Grade 4) infusion reaction.

Infections: Monitor patients for signs and symptoms of infection and treat promptly.

Autoimmune complications: Interrupt or permanently discontinue POTELIGEO as appropriate for suspected immune-mediated adverse reactions. Consider the benefit/risk of POTELIGEO in patients with a history of autoimmune disease.

Complications of allogeneic HSCT after POTELIGEO: Increased risks of transplant complications have been reported in patients who received allogeneic HSCT after POTELIGEO. Follow patients closely for early evidence of transplant-related complications.

ADVERSE REACTIONS

The most common adverse reactions (reported in ≥10% of patients) with POTELIGEO in the clinical trial were rash, including drug eruption (35%), infusion reaction (33%), fatigue (31%), diarrhea (28%), drug eruption (24%), upper respiratory tract infection (22%), musculoskeletal pain (22%), skin infection (19%), pyrexia (17%), edema (16%), nausea (16%), headache (14%), thrombocytopenia (14%), constipation (13%), anemia (12%), mucositis (12%), cough (11%), and hypertension (10%).

You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional Important Safety Information in full Prescribing Information as well as Patient Information.

About Kyowa Kirin
Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential to help patients with high unmet medical needs, such as bone & mineral, intractable hematological diseases/hemato-oncology, and rare diseases. A shared commitment to our values, to sustainable growth, and to making people smile unites us across the globe. You can learn more about the business of Kyowa Kirin at www.kyowakirin.com.

CONTACT: 
Susan Thiele
Head of Therapeutic Communications, North America
[email protected]

GlobeNewswire Distribution ID 9734113

Posted on

Synack and Wolfpack Information Risk Bring Sara AI Pentesting to Organizations Across South Africa

Established partnership helps companies move from point-in-time testing to continuous security validation with AI + human expertise

REDWOOD CITY, Calif., June 10, 2026 (GLOBE NEWSWIRE) — Synack, the AI + human penetration testing platform is expanding its partnership with Wolfpack Information Risk, a South Africa-based specialist cybersecurity firm, to bring Sara AI Pentesting to organizations across South Africa.

Sara AI Pentesting, powered by the Synack Autonomous Red Agent, combines agentic AI with the Synack Red Team (SRT), a globally vetted community of elite ethical hackers. Together, Sara AI Pentesting and the SRT help organizations expand coverage across their attack surface, accelerate testing, and validate real-world exploitability with greater speed and confidence.

Wolfpack Information Risk, established in 2011 and a B-BBEE Level 1-certified company, brings deep expertise in governance, risk and compliance, penetration testing, cybersecurity consulting, and security operations to organizations across the region. Through its partnership with Synack, Wolfpack enables clients to adopt a modern model of continuous security validation, moving beyond periodic testing toward always-on assurance.

The longstanding partnership has already delivered measurable value for customers. Leading organisations across the financial services, mining, and telecommunications sectors have engaged Synack through Wolfpack to address critical challenges in their controls assurance programme, including extended lead times, expansive technology footprints, and the need for continuous testing across rapidly changing codebases. The result has been faster pre-deployment testing, significantly reduced repeat findings, and improved mean time to remediation (MTTR).

As attack surfaces expand and the time between vulnerability discovery and exploitation continues to shrink, organizations need security testing that keeps pace with modern adversaries. Sara AI Pentesting helps accelerate reconnaissance, attack surface mapping, and initial exploit validation at scale, while the SRT validates what is real, exploitable, and relevant to the business.

Synack and Wolfpack will further explore these themes during a joint webinar, “AI + Human: Keeping Pace with the Modern Adversary,” on June 23, 2026. The session will discuss how companies can use continuous security validation to improve attack surface risk management, accelerate remediation, and strengthen resilience against evolving threats.

“Giving organisations access to continuous security validation—not periodic testing—is what drives the way we build our channel,” said Angela Heindl-Schober, Chief Marketing Officer at Synack. “Wolfpack brings deep security expertise and strong relationships, and together we’re ensuring our customers have what they need to stay ahead of threats.”

“Partnering with Synack gives our clients access to a level of continuous security validation that simply was not available to them before,” said Craig Rosewarne, Managing Director of Wolfpack Information Risk. “By combining Sara AI Pentesting, the Synack Red Team, and Wolfpack’s local expertise, organizations across our markets can move toward ongoing assurance and know that findings are real, validated, and actionable.”

Organizations interested in learning more about this partnership can visit wolfpackrisk.com/synack.

About Wolfpack Information Risk

Wolfpack Information Risk is a specialist cybersecurity, privacy, and resilience company headquartered in South Africa. A B-BBEE Level 1-certified firm established in 2011, Wolfpack serves organisations across all key sectors with services spanning governance, risk and compliance, penetration testing, cybersecurity operations, and awareness training. For more information, visit wolfpackrisk.com.

About Synack

Synack delivers continuous pentesting through its Human + AI platform for continuous security validation. Sara AI Pentesting, powered by the Synack Autonomous Red Agent, combines agentic AI with the Synack Red Team—the world’s most rigorously vetted community of security researchers—to help organizations proactively reduce risk, stay compliant, and stay ahead of evolving cyber threats. Sara handles reconnaissance, attack surface mapping, and initial exploit validation at scale, while human experts validate real-world exploitability and provide the creativity and judgement automation cannot replicate. Founded by former NSA operatives, Synack has enabled nearly 10 million hours of security testing to protect critical assets, from global financial systems to U.S. Defense Department networks. Synack was recognized by both G2 and GigaOm as a Leader in Penetration Testing and PTaaS. Learn more at synack.com.

Media Contact
Katy Nally
Senior Content Marketing Manager
[email protected]

GlobeNewswire Distribution ID 9734731

Posted on

Bitget Launches Anti-Scam Month 2026, Recovers $32.3 Million for Users

Bitget Launches Anti-Scam Month 2026, Recovers $32.3 Million for Users

Bitget Launches Anti-Scam Month 2026, Recovers $32.3 Million for Users

VICTORIA, Seychelles, June 09, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched Anti-Scam Month 2026 under the theme “More Assets, Stronger Shield. Stay Safe in the Multi-Asset Era.” The annual initiative focuses on helping users navigate an increasingly complex threat landscape as digital asset platforms expand beyond crypto into broader multi-asset ecosystems.

The campaign is accompanied by the release of key security and fraud prevention results from 2025. During the year, Bitget intercepted more than 150 million malicious attack requests, identified over 13,000 high-risk malicious IP addresses, and handled 18,135 user protection cases. The platform’s security team also helped users recover approximately $32.3 million linked to security incidents and fraudulent activity.

“The industry is entering a multi-asset era where users can access a wider range of products and markets through a single platform. As that access expands, security responsibilities increase too,” said Hon Ng, Chief Legal Officer at Bitget. “Protecting users requires continuous risk monitoring, rapid response mechanisms, security education, and close cooperation across the industry. Anti-Scam Month reflects the importance of building those protections alongside product innovation.”

Throughout 2025, Bitget continued to strengthen its security framework across account protection, asset custody, fraud prevention, and platform risk management. The platform expanded Passkey authentication capabilities based on FIDO2 and WebAuthn standards, enhanced multi-factor authentication coverage for high-risk account actions, strengthened anti-phishing protections, and improved device management controls that allow users to monitor and manage account access in real time.

Bitget also expanded its real-time threat detection and web security infrastructure in 2025. Security systems recorded more than 2.8 billion interceptions through custom protection rules and mitigated over 1.5 billion DDoS-related attack attempts. The platform’s monitoring capabilities were further enhanced through machine learning-based behavioral analysis designed to identify suspicious activity and emerging threats across multiple layers of the ecosystem.

User education remained a major focus of Bitget’s security strategy. Anti-Scam Month campaigns conducted across 2024 and 2025 reached approximately 1.38 billion users globally through security awareness content, educational resources, and community engagement initiatives. The company also expanded its Anti-Scam Hub, maintained its public bug bounty program, and introduced interactive initiatives such as the Smarter Eyes Challenge, which attracted close to 50,000 participants through simulated phishing and scam detection exercises.

Bitget continued to collaborate with leading blockchain security organizations, including SlowMist and Elliptic, to support threat intelligence sharing, anti-fraud research, and broader industry awareness efforts. Through a combination of platform security, user education, and industry cooperation, the company continues to invest in creating a safer environment for users navigating digital and tokenized financial markets.

Read our CLO’s letter here: https://www.bitget.com/blog/articles/bitget-clo-letter-more-assets-mean-more-responsibility

For more information, visit: https://www.bitget.com/events/antiscamhub

About Bitget

Bitget is the world’s largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 100+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships with LALIGA and MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry’s lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord

For media inquiries, please contact: [email protected]

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/cb6574f4-b2ab-4d1a-911f-2be535c75afc

GlobeNewswire Distribution ID 1001186360

Posted on

SOUEAST S08 DM Makes African Market Debut with Morocco Launch

CASABLANCA, Morocco, June 09, 2026 (GLOBE NEWSWIRE) — SOUEAST officially launched the S08 DM in Morocco. Positioned as a 7-Seat Urban Comfort SUV, the model debuted in the African market following its launches in the Middle East and Latin America. Over 500 guests attended the launch event, including media representatives, customers, and business partners. Maître Gims also attended the event as SOUEAST Morocco’s brand ambassador and delivered a live performance..

SOUEAST S08 DM
20260609-112643

SOUEAST officially launched the S08 DM in Morocco. Positioned as a 7-Seat Urban Comfort SUV, the model debuted in the African market following its launches in the Middle East and Latin America.

C-DM Hybrid Technology, Ready for Africa’s Roads

Africa is currently transitioning from traditional fuel-powered vehicles to new energy mobility. In this context, the S08 DM, equipped with C-DM high-efficiency hybrid technology, delivers exceptional practical value. It offers an NEDC combined driving range of over 1,300 km, helping reduce concerns about long-distance travel. In low-battery conditions, the vehicle consumes only 5.3 liters per 100 kilometers, significantly reducing operating costs and highlighting its economic advantages. Compared to single powertrain systems, this hybrid architecture provides greater flexibility in adapting to diverse scenarios, better meeting users’ varied driving needs.

Road conditions across Africa are highly varied and demanding. In cities, traffic is often heavy and stop-and-go. On the outskirts, gravel and unpaved roads are common, while mountain areas feature sharp turns and long climbs. These conditions require robust power delivery and precise handling. The S08 DM is powered by a 1.5TD + 1DHT Super Hybrid Powertrain, delivering a combined output of up to 255 kW for responsive urban driving. It also produces 3,750 N·m of wheel-end peak torque, improving hill-climbing ability and traction in challenging terrain. For stability and safety, the vehicle features a Bosch ESP system with a braking response time of just 150 ms, ensuring greater control in dynamic driving conditions.

7-Seater and V2L Power, Ideal for Family Outdoor Life

Family outings and weekend getaways become increasingly popular. Large interior space is therefore a top priority for many buyers. The SOUEAST S08 DM meets this demand with a 4,810 mm overall length and a 2,820 mm wheelbase, offers a three-row, seven-seat layout that provides generous space for passengers and luggage. For in-cabin convenience, it features a 6.4L armrest refrigerator. It is powered by an independent compressor and offers a wide temperature range from -6°C to 6°C and 35°C to 50°C. It can also cool from 30°C to 0°C in just 10 minutes, perfect for delivering refreshing beverages even in temperatures exceeding 40℃. Additionally, the S08 DM comes standard with a 3.3 kW V2L function, enabling users to easily power outdoor cooking, lighting, and entertainment system and offering a more convenient and flexible outdoor lifestyle.

SOUEAST Ranks No.3 Among Chinese Brands in Morocco

SOUEAST entered the Moroccan market in June 2025. Since then, it has introduced the S05, S06, S06 DM, S07, and S09. The lineup covers a wide range of urban family mobility needs under the brand philosophy “EASE YOUR LIFE.” The brand has quickly gained strong recognition in the local market. In the first quarter of this year, SOUEAST ranked Top 3 among Chinese automotive brands in Morocco. The S08 DM will also launch in Egypt and other African markets soon, further strengthening its presence in the region.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67d9bcf7-e5d4-4e38-b43e-6d8aa5a9174d

Company: Fujian Soueast Automobile Sales Co., Ltd

Contact Person: Weitong Liu

Email: [email protected]

Website: https://www.soueast-motor.com

GlobeNewswire Distribution ID 9733942

Posted on

ChemOne’s Pengerang Energy Complex Project Awards EPCC Works to CNCEC

SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) — Pengerang Energy Complex Sdn. Bhd. (“PEC”) is pleased to announce the award of the Engineering, Procurement, Construction and Commissioning (“EPCC”) works for the Pengerang Energy Complex Project (“Project”) in Johor, Malaysia to China National Chemical Engineering Company Limited (“CNCEC”).

The award marks a significant milestone for PEC as it advances through the final approval process with global Export Credit Agencies and project finance lenders.

CNCEC was selected following a rigorous evaluation process that considered technical expertise, financial strength, and project execution capabilities. As a leading global engineering and construction group, CNCEC brings the resources, extensive experience in world-scale energy and petrochemical projects, and familiarity with Honeywell UOP technologies, which form a key part of PEC’s process design. Supported by a strong track record of delivering large-scale projects safely, efficiently, and on schedule, CNCEC is a highly capable partner for the successful execution of the Pengerang Energy Complex.

Commenting on the award, a PEC spokesperson said:

“The award of the EPCC works to CNCEC marks an important milestone for the Pengerang Energy Complex Project. It reflects the Project’s continued progress towards construction and our commitment to delivering a world-scale facility.”

This collaboration also marks a significant step in strengthening the strategic partnership between PEC and CNCEC and is expected to support future opportunities for cooperation on PEC’s planned energy and petrochemical developments.

About Pengerang Energy Complex (www.pengerangenergy.com)

The Pengerang Energy Complex (PEC) is a world-scale integrated refinery and petrochemical development located in Johor, Malaysia. Designed to produce transportation fuels, aromatics, and petrochemical products for international markets, PEC is strategically positioned within the Johor–Singapore Special Economic Zone and is expected to play a key role in enhancing regional energy security, industrial development, and sustainable economic growth.

About CNCEC

China National Chemical Engineering Co., Ltd. (CNCEC) is a leading global engineering, procurement, and construction (EPC) contractor specializing in chemical, petrochemical, refining, energy, and industrial infrastructure projects. With extensive international experience and a strong track record of delivering large-scale projects across multiple continents, CNCEC is recognized for its engineering excellence, execution capabilities, and commitment to quality, safety, and sustainable development.

For media enquiries, please contact:

Kokila Sundram
M: +65 9170 0507
E: [email protected]

Zoe Shi
M: +65 9892 5881
E: [email protected]

GlobeNewswire Distribution ID 9733941

Posted on

Holafly partners with ATP Top 20 doubles player Francisco Cabral

Holafly Global Brand Ambassador Francisco Cabral

ATP Top 20 doubles player Francisco Cabral has joined Holafly as a global brand ambassador. As part of the partnership, the highest-ranked Portuguese doubles player in ATP history will share moments from life on the ATP Tour. This content will showcase how athletes stay prepared during constant travel.

DUBLIN, June 09, 2026 (GLOBE NEWSWIRE) — Holafly, the global leader in travel eSIMs, today announced a new partnership with ATP Top 20 doubles player Francisco Cabral, who joins the company as a global brand ambassador. The collaboration brings together one of the world’s leading eSIM companies with one of tennis’ most internationally active players.

Few athletes embody modern international travel quite like Cabral. The Portuguese star competes in approximately 35 to 40 tournaments each season across Europe, North America, Asia, Australia and the Middle East. Constant adaptation to new countries, cultures, climates and time zones means his experience closely reflects the realities faced by millions of international travellers every day.

Cabral has firmly established himself as one of the most consistent doubles players on the ATP Tour, reaching a career-high ranking of World No. 19 and becoming the highest-ranked Portuguese doubles player in ATP history. His career includes six ATP Tour doubles titles, fifteen ATP Challenger titles and appearances at all four Grand Slam tournaments. In 2022, he and Nuno Borges became the first all-Portuguese team to win the Estoril Open, while his recent quarterfinal run at the Australian Open further cemented his place among the world’s leading doubles players.

As part of the partnership, Cabral will share firsthand moments from life on the ATP Tour, offering fans a clear view into the realities of competing around the world, from packed tournament schedules and long-haul journeys to the challenges that come with constant travel.

The collaboration will also spotlight Holafly’s Always On feature, which includes 1GB of backup data at no extra cost. Always On is designed to provide travellers with added reassurance during unexpected situations, ensuring they have a backup plan when they need it most.

“Francisco represents a new generation of athletes whose careers take them all over the world. Every season means new countries, new cities and new challenges, but also incredible opportunities. His journey reflects the way millions of people travel today, which makes him a natural fit for Holafly and everything we stand for,” said Daniela Prado, Brand Director at Holafly.

The partnership begins as Cabral continues to compete on some of the biggest stages in professional tennis, including Wimbledon, the US Open and the Australian Open. Throughout the season, Holafly and Cabral will bring fans closer to life beyond the court, highlighting the experiences that come with competing around the world.

As careers become increasingly international, the partnership between Holafly and Francisco Cabral reflects a shared belief that exploring the world should be shaped by opportunity, not uncertainty.

Media contact: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c23e9253-e001-41fb-a80a-38e89d0c1bd4

GlobeNewswire Distribution ID 1001186601